To include your compound in the COVID-19 Resource Center, submit it here.

J&J unit reports CellSearch data

Veridex LLC reported that an analysis of 841 patients in the Phase III COU-AA-301 trial of Zytiga abiraterone acetate showed

Read the full 205 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE